About this episode
Nov 6
ACOG POI Update (Oct 2026)
If you work in women’s health, you already know the golden rule: just when you think you’ve got a guideline memorized, the ink dries, and the updates drop. Medicine moves fast, and this month is no exception. Today, we are diving straight into the fresh-off-the-press October 2026 ... Show More
19m 18s
Nov 3
Myfembree as BC? ASRM Data
Back in 2021, we discussed the FDA approval of a combination GNRH antagonist (relagolix) with estradiol and norethindrone. This was originally approved to treat uterine fibroid related heavy menstrual bleeding. It is also now approved for endometriosis care. In theory, this shoul ... Show More
18m 3s
Oct 31
Maternal Fragile X Carrier: NEXT STEPS
Today, we’re diving into a topic that has completely transformed prenatal care over the past decade—non-invasive prenatal testing, or NIPT. Thanks to recent technological leaps, cfDNA, cell-free fetal DNA, is giving us unprecedented visibility through just a simple maternal blood ... Show More
20m 53s
Oct 2024
Chemotherapy: IPC and HIPEC
In this episode, we discuss Intraperitoneal chemotherapy (IPC) and Heated Intraperitoneal Chemotherapy (HIPEC), including clinical trials of these agents in ovarian cancer, complications and practical tips for utilizing HIPEC in clinical practice. Join us for bi-weekly episodes o ... Show More
31m 5s
Jun 2024
Ovarian cancer
<p>In this episode of PodMD, experienced sub-specialist Gynaecological Oncologist Dr Rhett Morton will be discussing the topic of ovarian cancer, including how a patient would typically present, the treatment options available, the warning signs to look out for, the likelihood of ... Show More
20m 15s
Oct 2024
Outdated: Cervix Part 2: Locally Advanced Cervical Cancer
This is the second of three episodes covering cervical cancer. In this episode, we define locally advanced, metastatic, and recurrent cervical cancer. We will discuss the standard treatment options, including chemotherapy and immunotherapy choices. Join us for bi-weekly episodes ... Show More
39m 43s
Aug 2023
Oncology | Ovarian Cancer
13m 28s
Mar 2025
Chemotherapy: Biologics
In this episode, we’ll be discussing biologic and other targeted therapies in gyn oncology, including indications and management of toxicities. Join us for bi-weekly episodes or check out our episode archive and show notes at readysetgyo.com. Follow us on Instagram @ReadySetGYOPo ... Show More
26m 47s
May 2022
Bradley J. Monk, MD, FACS, FACOG - When Are PARP Inhibitors the Best Choice for Patients With Ovarian Cancer? Personalizing Therapeutic Selection Across the Disease Continuum
Go online to PeerView.com/YWA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you optimizing the care of your patients with ovarian cancer with poly (ADP-ribose) polymerase (PARP) inhibitors and novel therapies such as tu ... Show More
56m 25s
Apr 2024
Episode 100: Colorectal Cancer Series, Pt. 2 - Adjuvant Therapy in Stage III Colon Cancer
<p class="" style="white-space:pre-wrap;">This week, we kick off our discussion of adjuvant systemic treatment in colon cancer, beginning with Stage III colon cancer. We will review the evidence basis for adjuvant therapy as well as the two main chemotherapy regimens including du ... Show More
38m 26s
Jun 2024
Episode 105: Colorectal Cancer Series, Pt. 7 - Management of Rectal Cancer
<p>This week, we incorporate medical oncology back into our discussion with our Radiation Oncologist, Dr. Sanford, and our Surgical Oncologist, Dr. Bailey. We discuss how we approach the management of localized rectal cancer. Note that we will be heavily building off our discussi ... Show More
32m 55s
Dec 2021
Oncology | Testicular Cancer
12m 35s
May 2025
JGO Weekly Summary (May 11, 2025)
In this episode of the JGO Podcast, we explore a recent study from Peking Union Medical College Hospital examining the role of adjuvant surgery in patients with high-risk chemorefractory or relapsed gestational choriocarcinoma who achieve complete remission following anti-PD-1 th ... Show More
4m 54s
In our previous episode, we covered the revised FIGO ovarian cancer staging which now includes fallopian tube and peritoneal malignancies. In this episode, we will cover the FIGO guidelines regarding the management of OVFTP cancer. What role do PARP inhibitors play? Does treatment for asymptotic recurrence based on CA125 help? Can tamoxifen be used in recurr ... Show More
<p>In this episode, we review the high-yield topic of <a href="https://step2.medbullets.com/oncology/120439/lung-cancer?hideLeftMenu=true"></a><a href="https://step2.medbullets.com/oncology/120459/ovarian-cancer?hideLeftMenu=true" target="_blank" rel="noopener noreferer">Ovarian ... Show More
<p>In this episode, we review the high-yield topic of <a href="https://step2.medbullets.com/oncology/121781/testicular-cancer">Testicular Cancer</a><a href="https://step2.medbullets.com/oncology/120388/squamous-cell-carcinoma"> </a>from the Oncology section.</p>
<p>Follow <a href ... Show More
